{
 "drug": "Chlorothiazide Oral Suspension",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/10/2026",
 "dayN": 196,
 "cat": "Cardiovascular",
 "companies": [
  "Salix Pharmaceuticals, a division of Bausch Health US, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/10/2026",
   "update_type": "New",
   "initial_posting_date": "02/10/2026",
   "package_ndc": "65649-311-12",
   "generic_name": "Chlorothiazide Oral Suspension",
   "contact_info": "800-321-4576",
   "openfda": {
    "application_number": [
     "NDA011870"
    ],
    "brand_name": [
     "DIURIL"
    ],
    "generic_name": [
     "CHLOROTHIAZIDE"
    ],
    "manufacturer_name": [
     "Salix Pharmaceuticals, Inc"
    ],
    "product_ndc": [
     "65649-311"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "CHLOROTHIAZIDE"
    ],
    "rxcui": [
     "213439",
     "309198"
    ],
    "spl_id": [
     "e311f727-9882-4c42-bd5b-e8e38ee54466"
    ],
    "spl_set_id": [
     "bd936e35-1af8-42da-bcc0-f22489d68574"
    ],
    "package_ndc": [
     "65649-311-12"
    ],
    "nui": [
     "N0000175359",
     "N0000175419",
     "M0471776"
    ],
    "pharm_class_pe": [
     "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
     "Thiazide Diuretic [EPC]"
    ],
    "pharm_class_cs": [
     "Thiazides [CS]"
    ],
    "unii": [
     "77W477J15H"
    ]
   },
   "update_date": "02/10/2026",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Oral Suspension",
   "presentation": "Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)",
   "company_name": "Salix Pharmaceuticals, a division of Bausch Health US, LLC",
   "status": "To Be Discontinued"
  }
 ]
}